RefloDx

RefloDx, is developing SondeFlux, an innovative non-invasive diagnostic devices for detecting and characterizing reflux in pediatric and adult populations.

Health and bio

Latest funding

$2M Seed · October 23, 2026

Source: app.dealroom.co

Funding history ↓

Website: reflodx.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Health Care, Health Diagnostics, Medical.

Stage: Seed.

Based in: Kaysville, United States.

Last round: Oct 23, 2026 · 5 days ago.

On Recent Funding since: Oct 24, 2026.

Signals

Website registeredAug 21, 2015 (11 years old)

Funding rounds

October 23, 2026
Seed · $2M
Source: app.dealroom.co
August 21, 2015
Website created

Team

AK
Andrew Knight CEO

Investors

NNational Science Foundation

Similar Health and bio companies

BBasalt Health$20M Series A · Oct 2026
AAtlas Bio$12.5M Seed · Oct 2026
CCent$15M Series A · Oct 2026
IImphatec$2M Seed · Oct 2026
Aadsilico$13.35M Series A · Oct 2026
CClinics On Cloud$12.61M Series A · Oct 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/reflodx (get a free API key).